ISBN 10: 1493923153 / ISBN 13: 9781493923151
Gebraucht / Anzahl: 0
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Wir haben Ihnen weitere Exemplare dieses Titels unten aufgelistet.

Beschreibung:

Brand New, Unread Copy in Perfect Condition. A+ Customer Service!. Buchnummer des Verkäufers

Über diesen Titel:

Bewertung (bereitgestellt von Goodreads):
0 durchschnittlich
(0 Bewertungen)

Inhaltsangabe:

This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these elements are integrated into drug product development. These chapters also discuss lessons learned from the FDA Office of Biotechnology Products pilot program. Following chapters demonstrate how QbD is used for formulation development ranging from screening of formulations to developability assessment to development of lyophilized and liquid formats. The next few chapters study the use of small-scale and surrogate models as well as QbD application to drug product processes such as drug substance freezing and thawing, mixing, sterile filtration, filling, lyophilization, inspection and shipping and handling.

Later chapters describe more specialized applications of QbD in the drug product realm. This includes the use of QbD in primary containers, devices and combination product development. The volume also explores QbD applied to vaccine development, automation, mathematical modeling and monitoring, and controlling processes and defining control strategies. It concludes with a discussion on the application of QbD to drug product technology transfer as well as overall regulatory considerations and lifecycle management. Quality by Design for Biopharmaceutical Drug Product Development is an authoritative resource for scientists and researchers interested in expanding their knowledge on QbD principles and uses in creating better drugs.

Über den Autor:

Dr. Feroz Jameel is a Principal Scientist for Parenteral Product & Process Development at Amgen Inc., in Thousand Oaks, CA, where he is involved in the development, optimization, scale-up and transfer to manufacturing of biopharmaceutical products. Feroz received his Master?s degree in Pharmaceutics from the University of Delhi and his Ph.D in Pharmaceutics from the University of Connecticut. His publications include a co-edited book, several book chapters and more than 40 peer-reviewed manuscripts and presentations.  He has held multiple leadership positions at the American Association of Pharmaceutical Scientists (AAPS) including chair of the freezing and drying technologies group and lead of the industrial consortium for application of QbD to lyophilization. He is a recipient of two patents in lyophilization formulation and lyophiliztion process development.  Dr. Jameel has received several awards including the AAPS and Parental Drug Association?s Fred Simon Award for the best paper published in the Journal of Pharmaceutical Science and Technology. He has also chaired several symposia on the development of biological products.

Dr. Susan A. Hershenson is the Deputy Director of Chemistry, Manufacturing and Controls at the Bill and Melinda Gates Foundation, where her major responsibilities are to support the CMC development and drug delivery needs for therapeutic projects funded by the Foundation.  She has many years of experience in drug development, including biologics, small molecules, combination products and drug delivery systems. Prior to the Gates Foundation, she served as President of Pharmaceutical Transformations LLC, a consulting service for the pharmaceutical, biotechnology, drug delivery and related industries.  Her clients included a wide range of biotechnology, pharmaceutical and drug delivery companies, start-ups, venture capitals, university labs and non-profit organizations.  Before starting her own practice, she served in a number of positions in the biopharmaceutical industry, including Vice President of Pharmaceutical and Device Development at Genentech and Vice President of Pharmaceutics at Amgen. During her career, Dr. Hershenson has made significant contributions to the development and commercialization of numerous therapeutic products including BETASERON®, Stemgen®, Kepivance®, Aranesp®, Neulasta®, Sensipar®, Nplate®, Vectibix®, Prolia®, XGEVA® and Nutropin AQ NuSpin® and has supported the development of numerous clinical candidates. She received her Ph.D. in Biochemistry from Yale University and held a postdoctoral fellowship in the laboratory of Dr. Robert Stroud at the University of California, San Francisco.  Dr. Hershenson publishes and teaches actively and serves on multiple scientific advisory boards.

Dr. Mansoor A. Khan is the Director of Product Quality Research and a Senior Biomedical Research Scientist at the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA), where he overseas research teams on biotech products, chemistry and stability, drug delivery systems and bioavailability/bioequivalence. Prior to joining the FDA, he was a Professor of Pharmaceutics and Director of the graduate program in the School of Pharmacy at Texas Tech University Health Sciences Center. He is a registered pharmacist and earned his Ph.D. in Industrial Pharmacy from the St. John's University School of Pharmacy. He has published more than 255 peer-reviewed manuscripts, four texts, 25 book chapters, 200 poster presentations, and more than 175 invited presentations worldwide. He has held several leadership positions at the American Association of Pharmaceutical Scientists (AAPS) including elected chair of pharmaceutics and drug delivery (PDD) and the founding chair of formulations design and development (FDD).  He serves on the editorial board of Pharmaceutical Technology, the International Journal of Pharmaceutics, AAPS PharmsciTech, and Drug Delivery and Translational Research.  He has received the AAPS Research Achievement Award in Formulations Design and Development and is an AAPS Fellow.

Dr. Sheryl Martin-Moe is an Executive Vice President at Enterprise Catalyst Group in Palo Alto, CA, where she consults for biotechnology, pharmaceutical and related companies and serves on scientific advisory boards. She has managed the development of more than 90 diverse drugs and combination products. She received her Ph.D. in Cell Biology from the University of Vermont and was a postdoctoral fellow in Biochemistry at the University of California, Berkeley. She worked at Sterling Drug in its research division and held management positions in various Development and Operation areas at Centocor, Bayer, and Genentech and was most recently Global Head of Pharmaceutical Development at Novartis Biologics in Basel, Switzerland. Her publications include two patents, two book chapters and 21 publications and invited presentations, including a publication that won the Parenteral Drug Association?s Fred Simon Award. Dr. Martin-Moe was a member of the CMC Biotech Working Group and co-authored its A-Mab case study for QbD.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Zustand: New

Beste Suchergebnisse bei AbeBooks

1.

Verlag: Springer (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 15
Print-on-Demand
Anbieter
European-Media-Service Mannheim
(Mannheim, Deutschland)
Bewertung
[?]

Buchbeschreibung Springer, 2015. Buchzustand: New. This item is printed on demand for shipment within 3 working days. Buchnummer des Verkäufers LP9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 219,69
Währung umrechnen

In den Warenkorb

Versand: EUR 4,49
Von Deutschland nach USA
Versandziele, Kosten & Dauer

2.

Feroz Jameel
Verlag: Springer-Verlag New York Inc. (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Anzahl: > 20
Print-on-Demand
Anbieter
Books2Anywhere
(Fairford, GLOS, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer-Verlag New York Inc., 2015. HRD. Buchzustand: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Buchnummer des Verkäufers IP-9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 231,32
Währung umrechnen

In den Warenkorb

Versand: EUR 10,43
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

3.

Verlag: Springer-Verlag New York Inc., United States (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 10
Anbieter
Book Depository hard to find
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer-Verlag New York Inc., United States, 2015. Hardback. Buchzustand: New. 2015 ed.. 239 x 165 mm. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these elements are integrated into drug product development. These chapters also discuss lessons learned from the FDA Office of Biotechnology Products pilot program. Following chapters demonstrate how QbD is used for formulation development ranging from screening of formulations to developability assessment to development of lyophilized and liquid formats. The next few chapters study the use of small-scale and surrogate models as well as QbD application to drug product processes such as drug substance freezing and thawing, mixing, sterile filtration, filling, lyophilization, inspection and shipping and handling. Later chapters describe more specialized applications of QbD in the drug product realm. This includes the use of QbD in primary containers, devices and combination product development.The volume also explores QbD applied to vaccine development, automation, mathematical modeling and monitoring, and controlling processes and defining control strategies. It concludes with a discussion on the application of QbD to drug product technology transfer as well as overall regulatory considerations and lifecycle management. Quality by Design for Biopharmaceutical Drug Product Development is an authoritative resource for scientists and researchers interested in expanding their knowledge on QbD principles and uses in creating better drugs. Buchnummer des Verkäufers LIE9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 234,65
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

4.

Feroz Jameel
Verlag: Springer-Verlag New York Inc. (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Anzahl: > 20
Print-on-Demand
Anbieter
Pbshop
(Wood Dale, IL, USA)
Bewertung
[?]

Buchbeschreibung Springer-Verlag New York Inc., 2015. HRD. Buchzustand: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Buchnummer des Verkäufers IP-9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 235,35
Währung umrechnen

In den Warenkorb

Versand: EUR 3,57
Innerhalb USA
Versandziele, Kosten & Dauer

5.

FEROZ JAMEEL
Verlag: Springer (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 1
Anbieter
Herb Tandree Philosophy Books
(Stroud, GLOS, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer, 2015. Hardback. Buchzustand: NEW. 9781493923151 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Buchnummer des Verkäufers HTANDREE0877143

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 236,36
Währung umrechnen

In den Warenkorb

Versand: EUR 9,27
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

6.

Jameel, Feroz
Verlag: Springer (2016)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Paperback Anzahl: 1
Print-on-Demand
Anbieter
Ria Christie Collections
(Uxbridge, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer, 2016. Paperback. Buchzustand: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Buchnummer des Verkäufers ria9781493923151_lsuk

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 240,66
Währung umrechnen

In den Warenkorb

Versand: EUR 4,49
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

7.

Verlag: Springer (2017)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Gebraucht Hardcover Anzahl: 2
Print-on-Demand
Anbieter
Murray Media
(North Miami Beach, FL, USA)
Bewertung
[?]

Buchbeschreibung Springer, 2017. Hardcover. Buchzustand: Very Good. This item is printed on demand. Buchnummer des Verkäufers P021493923153

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Gebraucht kaufen
EUR 270,10
Währung umrechnen

In den Warenkorb

Versand: EUR 2,67
Innerhalb USA
Versandziele, Kosten & Dauer

8.

Verlag: Springer (2017)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 2
Print-on-Demand
Anbieter
Murray Media
(North Miami Beach, FL, USA)
Bewertung
[?]

Buchbeschreibung Springer, 2017. Hardcover. Buchzustand: New. This item is printed on demand. Buchnummer des Verkäufers P111493923153

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 280,26
Währung umrechnen

In den Warenkorb

Versand: EUR 2,67
Innerhalb USA
Versandziele, Kosten & Dauer

9.

Verlag: Springer-Verlag New York Inc., United States (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 10
Print-on-Demand
Anbieter
The Book Depository
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer-Verlag New York Inc., United States, 2015. Hardback. Buchzustand: New. 2015 ed.. 239 x 165 mm. Language: English . Brand New Book ***** Print on Demand *****.This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these elements are integrated into drug product development. These chapters also discuss lessons learned from the FDA Office of Biotechnology Products pilot program. Following chapters demonstrate how QbD is used for formulation development ranging from screening of formulations to developability assessment to development of lyophilized and liquid formats. The next few chapters study the use of small-scale and surrogate models as well as QbD application to drug product processes such as drug substance freezing and thawing, mixing, sterile filtration, filling, lyophilization, inspection and shipping and handling. Later chapters describe more specialized applications of QbD in the drug product realm. This includes the use of QbD in primary containers, devices and combination product development.The volume also explores QbD applied to vaccine development, automation, mathematical modeling and monitoring, and controlling processes and defining control strategies. It concludes with a discussion on the application of QbD to drug product technology transfer as well as overall regulatory considerations and lifecycle management. Quality by Design for Biopharmaceutical Drug Product Development is an authoritative resource for scientists and researchers interested in expanding their knowledge on QbD principles and uses in creating better drugs. Buchnummer des Verkäufers APC9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 283,19
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

10.

Verlag: Springer-Verlag New York Inc., United States (2015)
ISBN 10: 1493923153 ISBN 13: 9781493923151
Neu Hardcover Anzahl: 10
Print-on-Demand
Anbieter
The Book Depository US
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Springer-Verlag New York Inc., United States, 2015. Hardback. Buchzustand: New. 2015 ed.. 239 x 165 mm. Language: English . Brand New Book ***** Print on Demand *****. This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these elements are integrated into drug product development. These chapters also discuss lessons learned from the FDA Office of Biotechnology Products pilot program. Following chapters demonstrate how QbD is used for formulation development ranging from screening of formulations to developability assessment to development of lyophilized and liquid formats. The next few chapters study the use of small-scale and surrogate models as well as QbD application to drug product processes such as drug substance freezing and thawing, mixing, sterile filtration, filling, lyophilization, inspection and shipping and handling. Later chapters describe more specialized applications of QbD in the drug product realm. This includes the use of QbD in primary containers, devices and combination product development.The volume also explores QbD applied to vaccine development, automation, mathematical modeling and monitoring, and controlling processes and defining control strategies. It concludes with a discussion on the application of QbD to drug product technology transfer as well as overall regulatory considerations and lifecycle management. Quality by Design for Biopharmaceutical Drug Product Development is an authoritative resource for scientists and researchers interested in expanding their knowledge on QbD principles and uses in creating better drugs. Buchnummer des Verkäufers APC9781493923151

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 283,89
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

Es gibt 8 weitere Exemplare dieses Buches

Alle Suchergebnisse ansehen